BRACE

(SLB-016) A Scoping Review of the Benefits and Risks of Prescription Stimulant Medications in Older Adults

(SLB-012) An Active-Comparator Restricted Disproportionality Analysis of Fluoroquinolone and the Risk of Panic Attacks

(A-048) Dupilumab Demonstrates a Higher Benefit-risk Score Compared with Upadacitinib: A Structured Benefit-risk Assessment of the HEADS UP Trial

(SLB-001) European perspectives on ethical aspects around utilization of patient registries for medicines decision-making

(SLB-015) Multiple Sclerosis Disease-Modifying Therapies and Human Papillomavirus-Related conditions: a disproportionality analysis from the WHO Vigibase

(A-047) Regulatory Flexibility in Drug Approval: A Comparative Analysis of U.S. Accelerated Approval and China’s Imported Drug Approval

(SLB-013) Structured benefit-risk assessment for isatuximab in transplant-ineligible newly diagnosed multiple myeloma patients

(SLB-014) The Effect of Antibiotics on the Risk of Parkinson’s Disease: A Meta-Analysis of Observational Epidemiological Studies

(SLB-011) The risk of suicidality with the use of 5-Alpha-Reductase Inhibitors: Real-world evidence utilizing the Food and Drug Administration Adverse Event Reporting System (FAERS)